iLeadBMS

iLeadBMS is a research-driven biotechnology company pioneering small molecule drug treatments for neurodegenerative diseases and cancer. Leveraging our unparalleled medicinal chemistry capabilities, the company offers a novel approach to addressing the highest unmet needs. Focused on the discovery and development of new drugs, iLeadBMS has a robust R&D pipeline targeting fibrotic diseases, protease inhibitors, solid tumors, and neurodegenerative disorders.